Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)

Summary

The study will enrol adult female and male patients with BRAF wild-type melanoma and brain metastases who are not eligible for surgery or radiosurgery and failed prior therapy with ipilimumab, and patients with BRAF V600 mutation-positive melanoma and brain metastases who are not eligible for surgery or radiosurgery and who failed prior therapy with a BRAF inhibitor.

Timeline

Start

2015-07

Primary completion

2017-12

Completion

2018-07

Drugs

Indications